wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26853642-F73756F0-005D-4F67-A56D-D54EF26E2CEA
Q26853642-F73756F0-005D-4F67-A56D-D54EF26E2CEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26853642-F73756F0-005D-4F67-A56D-D54EF26E2CEA
Emerging therapies for hepatitis C
P2860
Q26853642-F73756F0-005D-4F67-A56D-D54EF26E2CEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26853642-F73756F0-005D-4F67-A56D-D54EF26E2CEA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a01e8fc51daa3506ae73b4a430ee4223f9c9eec
P2860
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.